Reportable segments (Tables)

12 Months Ended

Dec. 31, 2021

Disclosure of entity's operating segments [Abstract]

Disclosure of entity's operating segments [text block]

Operating segment items as of December 31, 2021	Specialty plant nutrients			Iodine and its derivatives			Lithium and its derivatives			Industrial chemicals			Potassium			Other products and services			Reportable segments			Operating segments			Unallocated amounts			Total as of December 31, 2021
	ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$
Revenue		908,815			437,931			936,121			132,011			416,592			30,845			2,862,315			2,862,315			-			2,862,315
Revenues from transactions with other operating segments of the same entity		-			-			-			-			-			-			-			-			-			-
Revenues from external customers and transactions with other operating segments of the same entity		908,815			437,931			936,121			132,011			416,592			30,845			2,862,315			2,862,315			-			2,862,315
Costs of sales		(646,930	)		(240,341	)		(494,794	)		(109,067	)		(253,125	)		(27,951	)		(1,772,208	)		(1,772,208	)		-			(1,772,208	)
Administrative expenses		-			-			-			-			-			-			-			-			(118,893	)		(118,893	)
Finance expense		-			-			-			-			-			-			-			-			(84,626	)		(84,626	)
Depreciation and amortization expense		(58,808	)		(41,215	)		(65,014	)		(13,743	)		(35,290	)		(169	)		(214,239	)		(214,239	)		-			(214,239	)
The entity’s interest in the profit or loss of associates and joint ventures accounted for by the equity method		-			-			-			-			-			-			-			-			11,132			11,132
Income before taxes		261,885			197,590			441,327			22,944			163,467			2,894			1,090,107			1,090,107			(248,886	)		841,221
Income tax expense		-			-			-			-			-			-			-			-			(249,016	)		(249,016	)
Net income (loss)		261,885			197,590			441,327			22,944			163,467			2,894			1,090,107			1,090,107			(497,902	)		592,205
Assets		-			-			-			-			-			-			-			-			7,044,297			7,044,297
Equity-accounted investees		-			-			-			-			-			-			-			-			39,824			39,824
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts		-			-			-			-			-			-			-			-			152,663			152,663
Other Liabilities		-			-			-			-			-			-			-			-			3,828,326			3,828,326
Impairment loss of financial assets recognized in profit or loss																				-						(235	)		(235	)
Impairment loss of non-financial assets recognized in profit or loss		-			-			-			-			-			-			-			-			(6,060	)		(6,060	)
Cash flows from operating activities		-			-			-			-			-			-			-			-			822,520			822,520
Cash flows used in investing activities		-			-			-			-			-			-			-			-			(1,006,943	)		(1,006,943	)
Cash flows from financing activities		-			-			-			-			-			-			-			-			1,206,485			1,206,485

Operating segment items as of December 31, 2020	Specialty plant nutrients			Iodine and its derivatives			Lithium and its derivatives			Industrial chemicals			Potassium			Other products and  services			Reportable segments			Operating segments			Unallocated amounts			Total as of December 31, 2020
	ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$
Revenue		701,688			334,657			383,373			160,608			209,294			27,571			1,817,191			1,817,191			-			1,817,191
Revenues from transactions with other operating segments of the same entity		-			-			-			-			-			-			-			-			-			-
Revenues from external customers and transactions with other operating segments of the same entity		701,688			334,657			383,373			160,608			209,294			27,571			1,817,191			1,817,191			-			1,817,191
Costs of sales		(537,801	)		(168,499	)		(297,048	)		(119,092	)		(187,019	)		(24,862	)		(1,334,321	)		(1,334,321	)		-			(1,334,321	)
Administrative expenses		-			-			-			-			-			-			-			-			(107,017	)		(107,017	)
Finance expense		-			-			-			-			-			-			-			-			(82,199	)		(82,199	)
Depreciation and amortization expense		(55,335	)		(40,687	)		(56,092	)		(14,136	)		(34,570	)		(3,092	)		(203,912	)		(203,912	)		-			(203,912	)
The entity’s interest in the profit or loss of associates and joint ventures accounted for by the equity method		-			-			-			-			-			-			-			-			8,940			8,940
Income before taxes		163,887			166,158			86,325			41,516			22,275			2,709			482,870			482,870			(244,332	)		238,538
Income tax expense		-			-			-			-			-			-			-			-			(70,179	)		(70,179	)
Net income (loss)		163,887			166,158			86,325			41,516			22,275			2,709			482,870			482,870			(314,511	)		168,359
Assets		-			-			-			-			-			-			-			-			4,818,463			4,818,463
Equity-accounted investees		-			-			-			-			-			-			-			-			85,993			85,993
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts		-			-			-			-			-			-			-			-			358,009			358,009
Other Liabilities		-			-			-			-			-			-			-			-			2,655,885			2,655,885
Impairment loss of financial assets recognized in profit or loss		-			-			-			-			-			-			-			-			4,684			4,684
Impairment loss of non-financial assets recognized in profit or loss		-			-			-			-			-			-			-			-			(11,644	)		(11,644	)
Cash flows from operating activities		-			-			-			-			-			-			-			-			182,234			182,234
Cash flows used in investing activities		-			-			-			-			-			-			-			-			(167,091	)		(167,091	)
Cash flows from financing activities		-			-			-			-			-			-			-			-			(94,132	)		(94,132	)

Operating segment items as of December 31, 2019	Specialty plant nutrients			Iodine and its derivatives			Lithium and its derivatives			Industrial chemicals			Potassium			Other products and services			Reportable segments			Operating segments			Unallocated amounts			Total as of December 31, 2019
	ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$
Revenue		723,920			371,020			505,714			94,875			212,151			35,975			1,943,655			1,943,655			-			1,943,655
Revenues from transactions with other operating segments of the same entity		-			-			-			-			-			-			-			-			-			-
Revenues from external customers and transactions with other operating segments of the same entity		723,920			371,020			505,714			94,875			212,151			35,975			1,943,655			1,943,655			-			1,943,655
Costs of sales		(573,808	)		(230,468	)		(306,250	)		(63,590	)		(176,199	)		(33,288	)		(1,383,603	)		(1,383,603	)		-			(1,383,603	)
Administrative expenses		-			-			-			-			-			-			-			-			(117,180	)		(117,180	)
Finance expense		-			-			-			-			-			-			-			-			(76,939	)		(76,939	)
Depreciation and amortization expense		(67,700	)		(43,336	)		(45,238	)		(6,854	)		(37,691	)		(532	)		(201,351	)		(201,351	)		-			(201,351	)
The entity’s interest in the profit or loss of associates and joint ventures accounted for by the equity method		-			-			-			-			-			-			-			-			9,786			9,786
Income before taxes		150,112			140,552			199,464			31,285			35,952			2,687			560,052			560,052			(169,430	)		390,622
Income tax expense		-			-			-			-			-			-			-			-			(110,019	)		(110,019	)
Net income (loss)		150,112			140,552			199,464			31,285			35,952			2,687			560,052			560,052			(279,449	)		280,603
Assets		-			-			-			-			-			-			-			-			4,684,151			4,684,151
Equity-accounted investees		-			-			-			-			-			-			-			-			109,435			109,435
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts		-			-			-			-			-			-			-			-			110,021			110,021
Other Liabilities		-			-			-			-			-			-			-			-			2,549,679			2,549,679
Impairment loss of financial assets recognized in profit or loss		-			-			-			-			-			-			-			-			(1,057	)		(1,057	)
Impairment loss of non-financial assets recognized in profit or loss		-			-			-			-			-			-			-			-			(1,102	)		(1,102	)
Cash flows from operating activities		-			-			-			-			-			-			-			-			426,971			426,971
Cash flows used in investing activities		-			-			-			-			-			-			-			-			(485,471	)		(485,471	)
Cash flows from financing activities		-			-			-			-			-			-			-			-			105,896			105,896

22.3 Statement of comprehensive income classified by reportable segments based on groups of products

Items in the statement of comprehensive income as of December 31, 2021	Specialty plant nutrients			Iodine and its derivatives			Lithium and its derivatives			Industrial chemicals			Potassium			Other products and services			Corporate Unit			Total segments and Corporate unit
	ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$
Revenue		908,815			437,931			936,121			132,011			416,592			30,845			-			2,862,315
Costs of sales		(646,930	)		(240,341	)		(494,794	)		(109,067	)		(253,125	)		(27,951	)		-			(1,772,208	)
Gross profit		261,885			197,590			441,327			22,944			163,467			2,894			-			1,090,107
Other incomes by function		-			-			-			-			-			-			19,552			19,552
Administrative expenses		-			-			-			-			-			-			(118,893	)		(118,893	)
Other expenses by function		-			-			-			-			-			-			(60,605	)		(60,605	)
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9		-			-			-			-			-			-			(235	)		(235	)
Other losses		-			-			-			-			-			-			(2,638	)		(2,638	)
Financial income		-			-			-			-			-			-			4,668			4,668
Financial costs		-			-			-			-			-			-			(84,626	)		(84,626	)
Interest in the profit (loss) of associates and joint ventures accounted for by the equity method		-			-			-			-			-			-			11,132			11,132
Exchange differences		-			-			-			-			-			-			(17,241	)		(17,241	)
Profit (loss) before taxes		261,885			197,590			441,327			22,944			163,467			2,894			(248,886	)		841,221
Income tax expense		-			-			-			-			-			-			(249,016	)		(249,016	)
Profit (loss) net		261,885			197,590			441,327			22,944			163,467			2,894			(497,902	)		592,205

Items in the statement of comprehensive income as of December 31, 2020	Specialty plant nutrients			Iodine and its derivatives			Lithium and its derivatives			Industrial chemicals			Potassium			Other products and services			Corporate Unit			Total segments and Corporate unit
	ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$
Revenue		701,688			334,657			383,373			160,608			209,294			27,571			-			1,817,191
Cost of sales		(537,801	)		(168,499	)		(297,048	)		(119,092	)		(187,019	)		(24,862	)		-			(1,334,321	)
Gross profit		163,887			166,158			86,325			41,516			22,275			2,709			-			482,870
Other incomes by function		-			-			-			-			-			-			26,893			26,893
Administrative expenses		-			-			-			-			-			-			(107,017	)		(107,017	)
Other expenses by function		-			-			-			-			-			-			(99,612	)		(99,612	)
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9		-			-			-			-			-			-			4,684			4,684
Other losses		-			-			-			-			-			-			(5,313	)		(5,313	)
Financial income		-			-			-			-			-			-			13,715			13,715
Financial costs		-			-			-			-			-			-			(82,199	)		(82,199	)
Interest in the profit (loss) of associates and joint ventures accounted for by the equity method		-			-			-			-			-			-			8,940			8,940
Exchange differences		-			-			-			-			-			-			(4,423	)		(4,423	)
Profit (loss) before taxes		163,887			166,158			86,325			41,516			22,275			2,709			(244,332	)		238,538
Income tax expense		-			-			-			-			-			-			(70,179	)		(70,179	)
Profit (loss) from continuing operations		163,887			166,158			86,325			41,516			22,275			2,709			(314,511	)		168,359

Items in the statement of comprehensive income as of December 31, 2019	Specialty plant nutrients			Iodine and its derivatives			Lithium and its derivatives			Industrial chemicals			Potassium			Other products and services			Corporate Unit			Total segments and Corporate unit
	ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$			ThUS$
Revenue		723,920			371,020			505,714			94,875			212,151			35,975			-			1,943,655
Cost of sales		(573,808	)		(230,468	)		(306,250	)		(63,590	)		(176,199	)		(33,288	)		-			(1,383,603	)
Gross profit		150,112			140,552			199,464			31,285			35,952			2,687			-			560,052
Other incomes by function		-			-			-			-			-			-			18,218			18,218
Administrative expenses		-			-			-			-			-			-			(117,180	)		(117,180	)
Other expenses by function		-			-			-			-			-			-			(25,995	)		(25,995	)
Impairment of gains and review of impairment losses (impairment losses) determined in accordance with IFRS 9		-			-			-			-			-			-			(1,057	)		(1,057	)
Other losses		-			-			-			-			-			-			(383	)		(383	)
Financial income		-			-			-			-			-			-			26,289			26,289
Financial costs		-			-			-			-			-			-			(76,939	)		(76,939	)
Interest in the profit (loss) of associates and joint ventures accounted for by the equity method		-			-			-			-			-			-			9,786			9,786
Exchange differences		-			-			-			-			-			-			(2,169	)		(2,169	)
Profit (loss) before taxes		150,112			140,552			199,464			31,285			35,952			2,687			(169,430	)		390,622
Income tax expense		-			-			-			-			-			-			(110,019	)		(110,019	)
Profit (loss) from continuing operations		150,112			140,552			199,464			31,285			35,952			2,687			(279,449	)		280,603

Disclosure of geographical areas [text block]

Items as of December 31, 2021	Chile		Latin America and the Caribbean		Europe		North America		Asia and others		Total
	ThUS$		ThUS$		ThUS$		ThUS$		ThUS$		ThUS$
Revenue		219,648		326,287		482,765		558,002		1,275,613		2,862,315
Investment accounted for under the equity method		-		-		15,242		15,899		8,683		39,824
Intangible assets other than goodwill		89,019		496		6,996		1,809		81,338		179,658
Goodwill		22,979		86		11,531		-		-		34,596
Property, plant and equipment, net		1,815,997		671		11,380		3,704		180,473		2,012,225
Right-of-use assets		29,803		68		2,040		3,351		17,346		52,608
Other non-current assets		27,626		16		6		3,950		1,889		33,487
Non-current assets		1,985,424		1,337		47,195		28,713		289,729		2,352,398

Items as of December 31, 2020	Chile		Latin America and the Caribbean		Europe		North America		Asia and others		Total
	ThUS$		ThUS$		ThUS$		ThUS$		ThUS$		ThUS$
Revenue		153,745		159,990		380,126		427,572		695,758		1,817,191
Investment accounted for under the equity method		-		-		41,273		14,468		30,252		85,993
Intangible assets other than goodwill		95,934		565		825		2,274		78,809		178,407
Goodwill		23,065		-		18,901		-		-		41,966
Property, plant and equipment, net		1,667,824		642		12,592		3,494		52,767		1,737,319
Right-of-use assets		23,461		2,298		2,428		1,776		61		30,024
Other non-current assets		19,377		17		7		2,641		-		22,042
Non-current assets		1,829,661		3,522		76,026		24,653		161,889		2,095,751

Items as of December 31, 2019	Chile		Latin America and the Caribbean		Europe		North America			Asia and others		Total
	ThUS$		ThUS$		ThUS$		ThUS$			ThUS$		ThUS$
Revenue		211,857		161,928		393,764		451,272			724,834		1,943,655
Investment accounted for under the equity method		-		-		42,243		14,669			52,523		109,435
Intangible assets other than goodwill		106,910		420		1,397		2,683			76,948		188,358
Goodwill		23,205		-		11,521		-			-		34,726
Property, plant and equipment, net		1,526,919		513		3,424		6,250			32,800		1,569,906
Right-of-use assets		29,427		2,734		2,817		2,083			103		37,164
Other non-current assets		20,321		28		4		(624	)		-		19,729
Non-current assets		1,706,782		3,695		61,406		25,061			162,374		1,959,318